APA (7th ed.) Citation

Lu, M., Wang, X., Sun, N., Huang, S., Yang, L., & Li, D. (2024). Metabolomics of cerebrospinal fluid reveals candidate diagnostic biomarkers to distinguish between spinal muscular atrophy type II and type III. CNS Neuroscience & Therapeutics, 30(4), 1. https://doi.org/10.1111/cns.14718

Chicago Style (17th ed.) Citation

Lu, Mengnan, Xueying Wang, Na Sun, Shaoping Huang, Lin Yang, and Dan Li. "Metabolomics of Cerebrospinal Fluid Reveals Candidate Diagnostic Biomarkers to Distinguish Between Spinal Muscular Atrophy Type II and Type III." CNS Neuroscience & Therapeutics 30, no. 4 (2024): 1. https://doi.org/10.1111/cns.14718.

MLA (9th ed.) Citation

Lu, Mengnan, et al. "Metabolomics of Cerebrospinal Fluid Reveals Candidate Diagnostic Biomarkers to Distinguish Between Spinal Muscular Atrophy Type II and Type III." CNS Neuroscience & Therapeutics, vol. 30, no. 4, 2024, p. 1, https://doi.org/10.1111/cns.14718.